Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. Cash from investing

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Apr 30, 2024-32-59.03%
Apr 30, 2023-78+37.63%
Apr 30, 2022-56+471.89%
Apr 30, 2021-10+158.76%
Apr 30, 2020-4-183.89%
Apr 30, 20195-24015.79%
Apr 30, 2018-0-99.36%
Apr 30, 2017-3-65.97%
Apr 30, 2016-9+4.05%
Apr 30, 2015-8+235.01%
Apr 30, 2014-3+235.82%
Apr 30, 2013-1-35.87%
Apr 30, 2012-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat